Drug Type Antibody fusion proteins |
Synonyms MTfp-antibody fusion - biOasis Technologies, xB3-hIgG1-IL1RA, XB3 004 + [1] |
Target |
Action antagonists |
Mechanism IL1R1 antagonists(Interleukin-1 receptor alpha antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuralgia | Preclinical | United States | - | |
Neuralgia | Preclinical | Canada | - |